Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...

Three experts discuss the increased mortality risk for patients with diabetic retinopathy, available screening tools, and ...

Diabetic retinopathy, a common complication ... Diabetic patients may benefit from laser-assisted cataract surgery, which offers precise incisions and reduces the risk of complications such ...

Diabetic retinopathy (DR) is an important cause of avoidable blindness worldwide. Seventy percent of diabetes occur in low and lower-middle income countries. Clinical practice guidelines for the ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.